BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1126451)

  • 1. Artificial blood and the National Blood Policy.
    Surgenor DM; Mierzwa BD
    Fed Proc; 1975 May; 34(6):1518-21. PubMed ID: 1126451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent circumstances in the supply and demand of various blood products in Japan, and appropriate use of blood components or plasma protein derivatives].
    Tohyama H
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3095-104. PubMed ID: 3777947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of albumin, plasma substitutes and plasmapheresis: proceedings of a symposium organized by the International Association of Biological Standardization and held at the World Health Organization, Geneva, Switzerland, November 10-12, 1980.
    Dev Biol Stand; 1980; 48():1-323. PubMed ID: 7274551
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood transfusion safety in a limited resources setting: the elaboration of a rational National Blood Policy in Togo].
    Sodahlon YK; Segbena AY; Prince-David M; Gbo KA; Fargier MP; North ML; Malvy DJ
    Sante; 2004; 14(2):115-20. PubMed ID: 15454371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally occurring asbestos: a recurring public policy challenge.
    Lee RJ; Strohmeier BR; Bunker KL; Van Orden DR
    J Hazard Mater; 2008 May; 153(1-2):1-21. PubMed ID: 18180100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bloody mess. New safeguards will cut supplies of a lifesaving resource.
    Sobel RK
    US News World Rep; 2001 Sep; 131(8):36-9. PubMed ID: 11550392
    [No Abstract]   [Full Text] [Related]  

  • 7. Low supply plus military need equals blood-product shortage.
    Wagner M
    Mod Healthc; 1991 Feb; 21(8):30. PubMed ID: 10109264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alleviating blood shortages in a resource-constrained environment.
    Pitocco C; Sexton TR
    Transfusion; 2005 Jul; 45(7):1118-26. PubMed ID: 15987356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-referencing of ISO-9000 and regulatory quality systems at blood centers.
    Healy-Collier K
    Top Health Inf Manage; 1998 May; 18(4):32-8. PubMed ID: 10179274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The battle over blood collection.
    Stewart DW
    Am J Law Med; 1977; 3(1):77-88. PubMed ID: 868882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inspection of veterinary biologics in the United States.
    Randall DC
    Dev Biol Stand; 1992; 79():163-70. PubMed ID: 1286751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will regulation be the death of cell therapy in the United States?
    Gastineau DA
    Bone Marrow Transplant; 2004 Apr; 33(8):777-80. PubMed ID: 14968138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS and the blood supply: an analysis of law, regulation, and public policy.
    Salbu SR
    Wash Univ Law Q; 1996; 74(4):913-80. PubMed ID: 16273697
    [No Abstract]   [Full Text] [Related]  

  • 14. Revisions to the requirements applicable to blood, blood components, and source plasma. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Aug; 66(151):40886-90. PubMed ID: 11732557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
    Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current malaria situation in the Republic of Kazakhstan].
    Bismil'din FB; Shapieva ZhZh; Anpilova EN
    Med Parazitol (Mosk); 2001; (1):24-33. PubMed ID: 11548308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How FDA safeguards the blood supply.
    Stone BW
    FDA Consum; 1991 Jun; 25(5):12-5. PubMed ID: 10111728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delegations of authority and organization; Ryan White Comprehensive AIDS Resources Emergency Act of 1990--FDA. Final rule.
    Fed Regist; 1991 Aug; 56(167):42527. PubMed ID: 10113840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient safety or profit: what incentives are blood shield laws and FDA regulations creating for the tissue banking industry?
    Williams JL
    Indiana Health Law Rev; 2005; 2(1):295-328. PubMed ID: 17111505
    [No Abstract]   [Full Text] [Related]  

  • 20. Creating value-focused healthcare delivery systems: Part three--Core competencies.
    Beveridge RN
    J Oncol Manag; 1997; 6(6):16-23. PubMed ID: 10174597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.